We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Eaton, Nicholas R and Greene, Ashley L 2018. Personality disorders: community prevalence and socio-demographic correlates. Current Opinion in Psychology, Vol. 21, p. 28.
Keefe, John R. and DeRubeis, Robert J. 2018. Changing character: A narrative review of personality change in psychotherapies for personality disorder. Psychotherapy Research, p. 1.
Quirk, Shae E Berk, Michael Pasco, Julie A Brennan-Olsen, Sharon L Chanen, Andrew M Koivumaa-Honkanen, Heli Burke, Lisa M Jackson, Henry J Hulbert, Carol A Olsson, Craig Moran, Paul Stuart, Amanda L and Williams, Lana J 2017. The prevalence, age distribution and comorbidity of personality disorders in Australian women. Australian & New Zealand Journal of Psychiatry, Vol. 51, Issue. 2, p. 141.
Marono, Abbie Clarke, David D. Navarro, Joe and Keatley, David A. 2017. A Behaviour Sequence Analysis of Nonverbal Communication and Deceit in Different Personality Clusters. Psychiatry, Psychology and Law, p. 1.
Björkenstam, Emma Ekselius, Lisa Burström, Bo Kosidou, Kyriaki and Björkenstam, Charlotte 2017. Association between childhood adversity and a diagnosis of personality disorder in young adulthood: a cohort study of 107,287 individuals in Stockholm County. European Journal of Epidemiology, Vol. 32, Issue. 8, p. 721.
Kujansuu, Antti Rautiainen, Simo Hakko, Helinä Kanamüller, Juha Sihvola, Niina and Riipinen, Pirkko 2017. Drivers' psychiatric disorders and fatal motor vehicle accidents in Finland. Journal of Psychiatric Research, Vol. 84, p. 227.
Martino, Francesca Pala, Andrea Norcini Valenti, Barbara Capelli, Rossella Berardi, Domenico Bagrodia, Rohini and Menchetti, Marco 2017. Adaptation and Psychometric Evaluation of the Italian Version of the Attitude to Personality Disorder Questionnaire (APDQ). Journal of Personality Disorders, Vol. 31, Issue. 5, p. 709.
Herpertz, Stephan Kessler, Henrik and Jongen, Sebastian 2017. Psychosomatic and Psychosocial Questions Regarding Bariatric Surgery: What Do We Know, or What Do We Think We Know?. Zeitschrift für Psychosomatische Medizin und Psychotherapie, Vol. 63, Issue. 4, p. 344.
Karukivi, Max Vahlberg, Tero Horjamo, Kalle Nevalainen, Minna and Korkeila, Jyrki 2017. Clinical importance of personality difficulties: diagnostically sub-threshold personality disorders. BMC Psychiatry, Vol. 17, Issue. 1,
Kaess, Michael Ghinea, Denisa Fischer-Waldschmidt, Gloria and Resch, Franz 2017. Die Ambulanz für Risikoverhalten und Selbstschädigung (AtR!Sk) – ein Pionierkonzept der ambulanten Früherkennung und Frühintervention von Borderline-Persönlichkeitsstörungen. Praxis der Kinderpsychologie und Kinderpsychiatrie, Vol. 66, Issue. 6, p. 404.
Vaddiparti, Krishna and Cottler, Linda B. 2017. Personality disorders and pathological gambling. Current Opinion in Psychiatry, Vol. 30, Issue. 1, p. 45.
Katsakou, Christina and Pistrang, Nancy 2017. Clients’ experiences of treatment and recovery in borderline personality disorder: A meta-synthesis of qualitative studies. Psychotherapy Research, p. 1.
Grenyer, Brin FS Ng, Fiona YY Townsend, Michelle L and Rao, Sathya 2017. Personality disorder: A mental health priority area. Australian & New Zealand Journal of Psychiatry, Vol. 51, Issue. 9, p. 872.
Olajide, Kike Munjiza, Jasna Moran, Paul O'Connell, Lesley Newton-Howes, Giles Bassett, Paul Gbolagade, Akintomide Ng, Nicola Tyrer, Peter Mulder, Roger and Crawford, Mike J. 2017. Development and Psychometric Properties of the Standardized Assessment of Severity of Personality Disorder (SASPD). Journal of Personality Disorders, p. 1.
Newton-Howes, Giles M. Foulds, James A. Guy, Nicola H. Boden, Joseph M. and Mulder, Roger T. 2017. Personality disorder and alcohol treatment outcome: systematic review and meta-analysis. British Journal of Psychiatry, Vol. 211, Issue. 01, p. 22.
ALOSAIMI, FAHAD D. ALZAIN, NASSER ASIRI, SAEED FALLATA, EBTIHAJ ABALHASSAN, MOHAMMED QRMLI, ABDULAZIZ and ALHABBAD, ABDULHADI 2017. Patterns of psychiatric diagnoses in inpatient and outpatient psychiatric settings in Saudi Arabia. Archives of Clinical Psychiatry (São Paulo), Vol. 44, Issue. 3, p. 77.
ten Have, Margreet Verheul, Roel Kaasenbrood, Ad van Dorsselaer, Saskia Tuithof, Marlous Kleinjan, Marloes and de Graaf, Ron 2016. Prevalence rates of borderline personality disorder symptoms: a study based on the Netherlands Mental Health Survey and Incidence Study-2. BMC Psychiatry, Vol. 16, Issue. 1,
View all Google Scholar citations for this article.
Little is known about the cross-national population prevalence or correlates of personality disorders.
To estimate prevalence and correlates of DSM–IV personality disorder clusters in the World Health Organization World Mental Health (WMH) Surveys.
International Personality Disorder Examination (IPDE) screening questions in 13 countries (n = 21 162) were calibrated to masked IPDE clinical diagnoses. Prevalence and correlates were estimated using multiple imputation.
Prevalence estimates are 6.1% (s.e. = 0.3) for any personality disorder and 3.6% (s.e. = 0.3), 1.5% (s.e. = 0.1) and 2.7% (s.e. = 0.2) for Clusters A, B and C respectively. Personality disorders are significantly elevated among males, the previously married (Cluster C), unemployed (Cluster C), the young (Clusters A and B) and the poorly educated. Personality disorders are highly comorbid with Axis I disorders. Impairments associated with personality disorders are only partially explained by comorbidity.
Personality disorders are relatively common disorders that often co-occur with Axis I disorders and are associated with significant role impairments beyond those due to comorbidity.
To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.
To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.
This study was supported by the US National Institute of Mental Health (NIMH) (R01-MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01-DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly & Company Foundation, Ortho-McNeil Pharmaceutical Inc, GlaxoSmithKline and Bristol-Myers Squibb. A complete list of WMH publications can be found at www.hcp.med.harvard.edu/wmh/.
The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123), the Piedmont Region (Italy), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Lebanese National Mental Health Survey (LEBANON) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), Fogarty International, Act for Lebanon, anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Roche and Novartis. The Mexican National Comorbidity Survey (MNCS) is supported by the National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the Pan American Health Organization (PAHO). The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria) and the Federal Ministry of Health, Abuja, Nigeria. The South Africa Stress and Health Study (SASH) is supported by the US NIMH (R01-MH059575) and National Institute of Drug Abuse (NIDA) with supplemental funding from the South African Department of Health and the University of Michigan. The US National Comorbidity Survey Replication (NCS–R) is supported by the NIMH (U01-MH60220) with supplemental support from NIDA, the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (Grant 044708), and the John W. Alden Trust.
Declaration of interest
R.C.K has been a consultant for GlaxoSmithKline, Kaiser Permanente, Pfizer Inc, Sanofi-Aventis, Shire Pharmaceuticals and Wyeth-Ayerst. He has served on advisory boards for Eli Lilly & Company and Wyeth-Ayerst, and has had research support for his epidemiological studies from Bristol-Myers Squibb, Eli Lilly & Company, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Pharmaceuticals Inc, Pfizer Inc and Sanofi-Aventis.
This study was supported by the US National Institute of Mental Health (NIMH) (R01-MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01-DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly & Company Foundation, Ortho-McNeil Pharmaceutical Inc, GlaxoSmithKline and Bristol-Myers Squibb. A complete list of WMH publications can be found at www.hcp.med.harvard.edu/wmh/.
The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123), the Piedmont Region (Italy), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Lebanese National Mental Health Survey (LEBANON) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), Fogarty International, Act for Lebanon, anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Roche and Novartis. The Mexican National Comorbidity Survey (MNCS) is supported by the National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the Pan American Health Organization (PAHO). The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria) and the Federal Ministry of Health, Abuja, Nigeria. The South Africa Stress and Health Study (SASH) is supported by the US NIMH (R01-MH059575) and National Institute of Drug Abuse (NIDA) with supplemental funding from the South African Department of Health and the University of Michigan. The US National Comorbidity Survey Replication (NCS–R) is supported by the NIMH (U01-MH60220) with supplemental support from NIDA, the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (Grant 044708), and the John W. Alden Trust.
Declaration of interest
R.C.K has been a consultant for GlaxoSmithKline, Kaiser Permanente, Pfizer Inc, Sanofi-Aventis, Shire Pharmaceuticals and Wyeth-Ayerst. He has served on advisory boards for Eli Lilly & Company and Wyeth-Ayerst, and has had research support for his epidemiological studies from Bristol-Myers Squibb, Eli Lilly & Company, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Pharmaceuticals Inc, Pfizer Inc and Sanofi-Aventis.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Type | Description | Title | |
PDF
|
Supplementary materials |
Huang et al. supplementary material |
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
Abstract views reflect the number of visits to the article landing page.
* Views captured on Cambridge Core between 3rd January 2018 - 26th April 2018. This data will be updated every 24 hours.
Eaton, Nicholas R and Greene, Ashley L 2018. Personality disorders: community prevalence and socio-demographic correlates. Current Opinion in Psychology, Vol. 21, p. 28.
Keefe, John R. and DeRubeis, Robert J. 2018. Changing character: A narrative review of personality change in psychotherapies for personality disorder. Psychotherapy Research, p. 1.
Quirk, Shae E Berk, Michael Pasco, Julie A Brennan-Olsen, Sharon L Chanen, Andrew M Koivumaa-Honkanen, Heli Burke, Lisa M Jackson, Henry J Hulbert, Carol A Olsson, Craig Moran, Paul Stuart, Amanda L and Williams, Lana J 2017. The prevalence, age distribution and comorbidity of personality disorders in Australian women. Australian & New Zealand Journal of Psychiatry, Vol. 51, Issue. 2, p. 141.
Marono, Abbie Clarke, David D. Navarro, Joe and Keatley, David A. 2017. A Behaviour Sequence Analysis of Nonverbal Communication and Deceit in Different Personality Clusters. Psychiatry, Psychology and Law, p. 1.
Björkenstam, Emma Ekselius, Lisa Burström, Bo Kosidou, Kyriaki and Björkenstam, Charlotte 2017. Association between childhood adversity and a diagnosis of personality disorder in young adulthood: a cohort study of 107,287 individuals in Stockholm County. European Journal of Epidemiology, Vol. 32, Issue. 8, p. 721.
Kujansuu, Antti Rautiainen, Simo Hakko, Helinä Kanamüller, Juha Sihvola, Niina and Riipinen, Pirkko 2017. Drivers' psychiatric disorders and fatal motor vehicle accidents in Finland. Journal of Psychiatric Research, Vol. 84, p. 227.
Martino, Francesca Pala, Andrea Norcini Valenti, Barbara Capelli, Rossella Berardi, Domenico Bagrodia, Rohini and Menchetti, Marco 2017. Adaptation and Psychometric Evaluation of the Italian Version of the Attitude to Personality Disorder Questionnaire (APDQ). Journal of Personality Disorders, Vol. 31, Issue. 5, p. 709.
Herpertz, Stephan Kessler, Henrik and Jongen, Sebastian 2017. Psychosomatic and Psychosocial Questions Regarding Bariatric Surgery: What Do We Know, or What Do We Think We Know?. Zeitschrift für Psychosomatische Medizin und Psychotherapie, Vol. 63, Issue. 4, p. 344.
Karukivi, Max Vahlberg, Tero Horjamo, Kalle Nevalainen, Minna and Korkeila, Jyrki 2017. Clinical importance of personality difficulties: diagnostically sub-threshold personality disorders. BMC Psychiatry, Vol. 17, Issue. 1,
Kaess, Michael Ghinea, Denisa Fischer-Waldschmidt, Gloria and Resch, Franz 2017. Die Ambulanz für Risikoverhalten und Selbstschädigung (AtR!Sk) – ein Pionierkonzept der ambulanten Früherkennung und Frühintervention von Borderline-Persönlichkeitsstörungen. Praxis der Kinderpsychologie und Kinderpsychiatrie, Vol. 66, Issue. 6, p. 404.
Vaddiparti, Krishna and Cottler, Linda B. 2017. Personality disorders and pathological gambling. Current Opinion in Psychiatry, Vol. 30, Issue. 1, p. 45.
Katsakou, Christina and Pistrang, Nancy 2017. Clients’ experiences of treatment and recovery in borderline personality disorder: A meta-synthesis of qualitative studies. Psychotherapy Research, p. 1.
Grenyer, Brin FS Ng, Fiona YY Townsend, Michelle L and Rao, Sathya 2017. Personality disorder: A mental health priority area. Australian & New Zealand Journal of Psychiatry, Vol. 51, Issue. 9, p. 872.
Olajide, Kike Munjiza, Jasna Moran, Paul O'Connell, Lesley Newton-Howes, Giles Bassett, Paul Gbolagade, Akintomide Ng, Nicola Tyrer, Peter Mulder, Roger and Crawford, Mike J. 2017. Development and Psychometric Properties of the Standardized Assessment of Severity of Personality Disorder (SASPD). Journal of Personality Disorders, p. 1.
Newton-Howes, Giles M. Foulds, James A. Guy, Nicola H. Boden, Joseph M. and Mulder, Roger T. 2017. Personality disorder and alcohol treatment outcome: systematic review and meta-analysis. British Journal of Psychiatry, Vol. 211, Issue. 01, p. 22.
ALOSAIMI, FAHAD D. ALZAIN, NASSER ASIRI, SAEED FALLATA, EBTIHAJ ABALHASSAN, MOHAMMED QRMLI, ABDULAZIZ and ALHABBAD, ABDULHADI 2017. Patterns of psychiatric diagnoses in inpatient and outpatient psychiatric settings in Saudi Arabia. Archives of Clinical Psychiatry (São Paulo), Vol. 44, Issue. 3, p. 77.
ten Have, Margreet Verheul, Roel Kaasenbrood, Ad van Dorsselaer, Saskia Tuithof, Marlous Kleinjan, Marloes and de Graaf, Ron 2016. Prevalence rates of borderline personality disorder symptoms: a study based on the Netherlands Mental Health Survey and Incidence Study-2. BMC Psychiatry, Vol. 16, Issue. 1,
View all Google Scholar citations for this article.
DSM–IV personality disorders in the WHO World Mental Health Surveys
eLetters
No eLetters have been published for this article.